The total return over the past 12 months is +1.08% vs. +15.54% for the S&P 500. So far it's up -12.01% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +1.08% | +0.47% | (22.35%) | N/A | N/A | N/A |
| Total Return CAGR | +1.08% | +0.47% | (22.35%) | N/A | N/A | N/A |
| Revenue CAGR | +158.88% | +24.85% | +479.04% | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Beam Therapeutics Inc. (BEAM)
| Year | Start price | End price | BEAM Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $27.72 | $24.39 | (12.01%) | +12.91% | (24.92%) |
| 2025 | $24.80 | $27.72 | +11.77% | +17.72% | (5.95%) |
| 2024 | $27.22 | $24.80 | (8.89%) | +24.89% | (33.78%) |
| 2023 | $39.11 | $27.22 | (30.40%) | +26.19% | (56.59%) |
| 2022 | $79.69 | $39.11 | (50.92%) | (18.17%) | (32.75%) |
| 2021 | $81.64 | $79.69 | (2.39%) | +28.74% | (31.13%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
